Comparison

RX-3117 European Partner

Item no. TMO-T16813-200mg
Manufacturer TargetMol
CASRN 865838-26-2
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C10H12FN3O4
Smiles Nc1ccn([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)c(=O)n1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias fluorocyclopentenylcytosine,TV-1360
Shipping Condition Cool pack
Available
Manufacturer - Targets
Nucleoside Antimetabolite/Analog
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
257.22
Description
RX-3117 (fluorocyclopentenylcytosine) is a novel a cytidine analog. RX-3117 displays anticancer activity in several cancer cell lines, including gemcitabine-resistant variants.
Pathways
DNA Damage/DNA Repair|||Cell Cycle/Checkpoint
Bioactivity
RX-3117 is a novel a cytidine analog. RX-3117 displays anticancer activity in several cancer cell lines, including gemcitabine-resistant variants.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close